Fluoroscopically guided hysteroscopic division of adhesions in severe Asherman syndrome
- PMID: 10362178
- DOI: 10.1016/s0029-7844(99)00245-8
Fluoroscopically guided hysteroscopic division of adhesions in severe Asherman syndrome
Abstract
Background: Severe Asherman syndrome that is stage III disease according to the American Fertility Society, with obliteration of the uterine cavity and the inability to visualize isolated pockets of the intrauterine cavity, makes safe and effective hysteroscopic division of adhesions difficult, if not impossible.
Technique: A 16-gauge, 80-mm Tuohy needle is introduced into the endocervical canal alongside a 5-mm diagnostic hysteroscope. The surgeon probes the area beyond the adhesion with the needle. Ultravist 76.9% is injected through the needle under fluoroscopic and hysteroscopic control. Hidden pockets of endometrium can be located radiographically, a passageway is created using the needle, and subsequent division of adhesions is performed under direct vision with hysteroscopic scissors.
Experience: Since 1984, approximately 55 women with severe Asherman syndrome have undergone this procedure. All patients required at least two procedures, and one woman required six. There have been two cases of uneventful perforation with the Tuohy needle, and all women resumed menstruation. No serious complications have occurred.
Conclusion: This technique provides an intraoperative fluoroscopic view of pockets of endometrium behind an otherwise blind-ending endocervical canal in women with severe Asherman syndrome, allowing guided division of adhesions and reducing the likelihood of perforation and formation of false passageways.
Similar articles
-
Hysteroscopic Lysis of Complex Uterine Adhesions After Interventional Radiology-Guided Access.J Minim Invasive Gynecol. 2024 Jan;31(1):17-18. doi: 10.1016/j.jmig.2023.10.020. Epub 2023 Oct 31. J Minim Invasive Gynecol. 2024. PMID: 37913919
-
Live birth rate and obstetric complications following the hysteroscopic management of intrauterine adhesions including Asherman syndrome.Hum Reprod. 2018 Oct 1;33(10):1847-1853. doi: 10.1093/humrep/dey237. Hum Reprod. 2018. PMID: 30239778
-
Results of centralized Asherman surgery, 2003-2013.Fertil Steril. 2015 Dec;104(6):1561-8.e1. doi: 10.1016/j.fertnstert.2015.08.039. Epub 2015 Oct 1. Fertil Steril. 2015. PMID: 26428306
-
Evaluation and treatment of infertile women with Asherman syndrome: an updated review focusing on the role of hysteroscopy.Reprod Biomed Online. 2020 Jul;41(1):55-61. doi: 10.1016/j.rbmo.2020.03.021. Epub 2020 Apr 28. Reprod Biomed Online. 2020. PMID: 32444259 Review.
-
Review of intrauterine adhesions.J Minim Invasive Gynecol. 2010 Sep-Oct;17(5):555-69. doi: 10.1016/j.jmig.2010.04.016. Epub 2010 Jul 24. J Minim Invasive Gynecol. 2010. PMID: 20656564 Review.
Cited by
-
The role of preoperative 3D-ultrasound in intraoperative judgement for hysteroscopic adhesiolysis.Ann Transl Med. 2020 Feb;8(4):55. doi: 10.21037/atm.2020.01.06. Ann Transl Med. 2020. PMID: 32175349 Free PMC article.
-
Asherman's syndrome: current perspectives on diagnosis and management.Int J Womens Health. 2019 Mar 20;11:191-198. doi: 10.2147/IJWH.S165474. eCollection 2019. Int J Womens Health. 2019. PMID: 30936754 Free PMC article. Review.
-
A 10-year Review of the Clinical Presentation and Treatment Outcome of Asherman's Syndrome at a Center with Limited Resources.Ann Med Health Sci Res. 2015 Nov-Dec;5(6):442-6. doi: 10.4103/2141-9248.177984. Ann Med Health Sci Res. 2015. PMID: 27057384 Free PMC article.
-
Intrauterine infusion of platelet-rich plasma for severe Asherman syndrome: a cutting-edge approach.Updates Surg. 2021 Dec;73(6):2355-2362. doi: 10.1007/s13304-020-00828-0. Epub 2020 Jun 8. Updates Surg. 2021. PMID: 32514742 Review.
-
Asherman syndrome: Audit of a single-operator cohort of 423 cases.Aust N Z J Obstet Gynaecol. 2020 Aug;60(4):574-578. doi: 10.1111/ajo.13182. Epub 2020 May 26. Aust N Z J Obstet Gynaecol. 2020. PMID: 32458458 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources